Guanbao Keli (冠保颗粒)冠保颗粒

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

黄芪是一种在国家药监局注册认定的药品。该药品含有三七、丹参、当归-955c5af6等成分。

该药品关联的活性成分包括:三七San Qi、丹参salvia、当归Dang Gui、银杏叶Yinxing Ye、黄芪astragalus。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:华颐药业有限公司Chinese legal name: 华颐药业有限公司。

您可以探索含有相同成分的其他药品:三七-08b8ded9成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 冠保颗粒) is a medicine registered with the national drug regulatory authority. It contains salvia and other recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 三七San Qi, 丹参salvia, 当归Dang Gui, 银杏叶Yinxing Ye, 黄芪astragalus.

Manufacturers recorded for this product: 华颐药业有限公司Chinese legal name: 华颐药业有限公司.

Explore other medicines containing the same ingredient: 三七 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 冠保颗粒Recorded Chinese name: 冠保颗粒
  • 剂型Dosage form: 颗粒剂Granules
  • 规格Specification: 每袋装3g3 g per sachet

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 华颐药业有限公司Chinese legal name: 华颐药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字B20020073

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字B20020073

Manufacturer

Chinese legal name: 华颐药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字B20020073

生产企业

华颐药业有限公司(国产)

适应症

益气活血。适用于中风恢复期属气虚血瘀证候患者的康复和辅助治疗,症见半身不遂,舌强语蹇,气短乏力,自汗等。

用法用量

开水冲服。一次3g,一日3次。

不良反应

没有相关文献研究表明。

禁忌

尚不明确。

注意事项

1、出血性脑血管病急性期禁用;

2、建议在医生指导下使用。

贮藏

密封,置阴凉处。

规格

每袋装3g

证据Evidence

  • 批准文号: 国药准字B20020073
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.